Skip to main content
SpringerLink
Log in

No effect of timing of biopsy in the menstrual cycle on incidence of bone marrow micrometastasis in patients with breast cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The timing of breast cancer excision relative to the menstrual cycle has been debated to be of significant prognostic value. The differences in survival relative to the timing in the menstrual cycle have been attributed to the incidence of micrometastasis.

Methods: All patients underwent bone marrow aspiration after the diagnostic surgical biopsy, immediately before definitive surgery. The timing of the diagnostic surgical biopsy in the menstrual cycle was calculated according to Senie. Monoclonal antibodies to epithelium-specific antigens were used to detect bone marrow micrometastasis (BMM).

Results: This study reports on the effect of the phase of the menstrual cycle on incidence of BMM after surgical biopsy. Ninety-two patients with regular cycles underwent bone marrow aspiration an average of 12 days (range 0–32 days) after biopsy. Thirty-nine patients had undergone biopsy during the follicular phase and 53 patients during the luteal phase. BMM were detected in 31% of patients (29 of 92). We observed BMM in 33% of patients (13 of 39) in the follicular phase and in 30% of patients (16 of 53) in the luteal phase. This difference is not significant (p>0.70). The mean number of cells detected and the presence of clumps of cells is similar in the two groups.

Conclusions: The incidence and characteristics of bone marrow micrometastases are independent of the timing of diagnostic excision biopsy in the menstrual cycle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hrushesky WJ, Bluming AZ, Gruber SA, Sothern RB. Menstrual influence on surgical cure of breast cancer.Lancet 1989;2:949–52 [erratum 1989;2:1290].

    CAS  PubMed  Google Scholar 

  2. Badwe RA, Gregory WM, Chaudary MA, et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.Lancet 1991;337:1261–4.

    Article  CAS  PubMed  Google Scholar 

  3. Senie RT, Rosen PP, Rhodes P, Lesser ML. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival.Ann Intern Med 1991;115:337–42.

    CAS  PubMed  Google Scholar 

  4. Veronesi U, Luini A, Marques LA, Vecchio MD. Effect of menstrual phase on surgical treatment of breast cancer.Lancet 1994;343:1545–7.

    Article  CAS  PubMed  Google Scholar 

  5. Corder AP, Cross M, Julious SA, Mullee MA, Taylor I. The timing of breast cancer surgery within the menstrual cycle.Postgrad Med J 1994;70:281–4.

    CAS  PubMed  Google Scholar 

  6. Donegan WL, Shah D. Prognosis of patients with breast cancer related to the timing of operation.Arch Surg 1993;128:309–13.

    CAS  PubMed  Google Scholar 

  7. Powles TJ, Ashley SE, Nash AG. Timing of surgery for breast cancer and menstrual cycle.Lancet 1991;337:1604.

    Google Scholar 

  8. McGuire WL, Hilsenbeck S, Clark GM. Optimal mastectomy timing.JNCI 1992;84:346–8.

    CAS  PubMed  Google Scholar 

  9. Lippman ME, Dickson RB, Bates S. Autocrine and paracrine growth regulation of human breast cancer.Breast Cancer Res Treat 1986;7:59–70.

    Article  CAS  PubMed  Google Scholar 

  10. Cote RJ, Rosen PP, Hakes TB. Monoclonal antibodies detect occult breast carcinoma metastases in bone marrow of patients with early stage disease.Am J Surg Pathol 1988;12:333–40.

    CAS  PubMed  Google Scholar 

  11. Osborne MP, Asina S, Wong GY, Old LJ, Cote RJ. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.Cancer Res 1989;49:2510–2513.

    CAS  PubMed  Google Scholar 

  12. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.J Clin Oncol 1991;9:1749–56.

    CAS  PubMed  Google Scholar 

  13. Mansi JL, Easton D, Berger U, et al. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up.Eur J Cancer 1991;27:1552–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Strang-Cornell Cancer Research Laboratory, Strang Cancer Prevention Center, and Breast Service, Department of Surgery, New York Hospital-Cornell Medical Center, New York, USA

    Hemant Singhal MD, Charles Potter BM &  Michael P. Osborne MD

Authors
  1. Hemant Singhal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles Potter BM
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael P. Osborne MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr. Singhal is now with the Department of Surgery, University of Wales College of Medicine, Cardiff, CF4 4XN United Kingdom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singhal, H., Potter, C. & Osborne, M.P. No effect of timing of biopsy in the menstrual cycle on incidence of bone marrow micrometastasis in patients with breast cancer. Annals of Surgical Oncology 4, 503–505 (1997). https://doi.org/10.1007/BF02303676

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303676

Key Words

Search

Navigation